Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Kotobuki also conducting research on COX-2 inhibitors

Aug. 19, 1998

New COX-2 inhibitors in early development at American Home

Aug. 18, 1998

Chiral aspects of the pharmacokinetics of flobufen: important implications for therapeutic use

Aug. 14, 1998

NSAID from Sigma-Tau is devoid of GI side effects

Aug. 13, 1998

Pfizer investigates COX-2 inhibitors as potential antiinflammatory agents

Aug. 13, 1998

Hoechst discovers modulators of leukocyte adhesion and migration

Aug. 12, 1998

COX-2 inhibitors selective for the human enzyme discovered at Nycomed Innovations

Aug. 11, 1998

Bayer discovers new MMP inhibitors for arthritic diseases

Aug. 11, 1998

FDA committee recommends approval of Arava for the treatment of rheumatoid arthritis

Aug. 11, 1998

Hoechst describes new compounds for rheumatoid arthritis and allergy

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...